These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20591821)

  • 1. Improving early breast cancer detection: focus on methylation.
    Suijkerbuijk KPM; van Diest PJ; van der Wall E
    Ann Oncol; 2011 Jan; 22(1):24-29. PubMed ID: 20591821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation and the detection of breast cancer.
    Brooks J; Cairns P; Zeleniuch-Jacquotte A
    Cancer Causes Control; 2009 Nov; 20(9):1539-50. PubMed ID: 19768562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Blood DNA Methylation Markers in Early Detection of Breast Cancer: A Systematic Literature Review.
    Guan Z; Yu H; Cuk K; Zhang Y; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):496-505. PubMed ID: 30487132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection.
    de Groot JS; Moelans CB; Elias SG; Jo Fackler M; van Domselaar R; Suijkerbuijk KP; Witkamp AJ; Sukumar S; van Diest PJ; van der Wall E
    Oncotarget; 2016 Apr; 7(17):24778-91. PubMed ID: 27028854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
    Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
    Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer.
    Shan M; Yin H; Li J; Li X; Wang D; Su Y; Niu M; Zhong Z; Wang J; Zhang X; Kang W; Pang D
    Oncotarget; 2016 Apr; 7(14):18485-94. PubMed ID: 26918343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
    Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
    Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
    Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
    Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients.
    Liu L; Sun L; Li C; Li X; Zhang Y; Yu Y; Xia W
    Biomed Mater Eng; 2015; 26 Suppl 1():S2217-22. PubMed ID: 26406001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation markers for early detection of women's cancer: promise and challenges.
    Wittenberger T; Sleigh S; Reisel D; Zikan M; Wahl B; Alunni-Fabbroni M; Jones A; Evans I; Koch J; Paprotka T; Lempiäinen H; Rujan T; Rack B; Cibula D; Widschwendter M
    Epigenomics; 2014 Jun; 6(3):311-27. PubMed ID: 25111485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients.
    Li Z; Guo X; Wu Y; Li S; Yan J; Peng L; Xiao Z; Wang S; Deng Z; Dai L; Yi W; Xia K; Tang L; Wang J
    Breast Cancer Res Treat; 2015 Feb; 149(3):767-79. PubMed ID: 25636590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN2A (p14(ARF)/p16(INK4a)) and ATM promoter methylation in patients with impalpable breast lesions.
    Delmonico L; Moreira Ados S; Franco MF; Esteves EB; Scherrer L; Gallo CV; do Nascimento CM; Ornellas MH; de Azevedo CM; Alves G
    Hum Pathol; 2015 Oct; 46(10):1540-7. PubMed ID: 26255234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
    Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
    J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
    Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
    Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients.
    Shukla S; Mirza S; Sharma G; Parshad R; Gupta SD; Ralhan R
    Epigenetics; 2006; 1(2):88-93. PubMed ID: 17998817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrantly methylated DNA as a biomarker in breast cancer.
    Kristiansen S; Jørgensen LM; Guldberg P; Sölétormos G
    Int J Biol Markers; 2013; 28(2):141-50. PubMed ID: 23564623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.